Detalhe da pesquisa
1.
A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling.
Mol Pharmacol
; 83(4): 835-47, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23348500
2.
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement.
J Pharmacol Exp Ther
; 347(2): 438-57, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23965381